Evidence map›Paper›PMID 37097212›Full record

ArticleAIDS research and human retroviruses2023

Multiplex Analysis of Cytokines and Chemokines in Persons Aging With or Without HIV.

Kyle W Kroll, Griffin Woolley, Karen Terry, Thomas A Premeaux, Cecilia M Shikuma, Michael J Corley, Scott Bowler, Lishomwa C Ndhlovu, R Keith Reeves

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kyle W KrollDivision of Innate and Comparative Immunology, Center for Human Systems Immunology, Duke University, School of Medicine, Durham, North Carolina, USA.
Griffin WoolleyDivision of Innate and Comparative Immunology, Center for Human Systems Immunology, Duke University, School of Medicine, Durham, North Carolina, USA.
Karen TerryDivision of Innate and Comparative Immunology, Center for Human Systems Immunology, Duke University, School of Medicine, Durham, North Carolina, USA.
Thomas A PremeauxDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Cecilia M ShikumaHawaii Center for AIDS, University of Hawaii, Honolulu, Hawaii, USA.ORCID 0000-0003-0114-1262
Michael J CorleyDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Scott BowlerDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Lishomwa C NdhlovuDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
R Keith ReevesDivision of Innate and Comparative Immunology, Center for Human Systems Immunology, Duke University, School of Medicine, Durham, North Carolina, USA.ORCID 0000-0003-3157-2557
Cornell University · USDuke University · USUniversity of Hawaiʻi at Mānoa · US

Funding

The Role of gp120 on Cardiovascular Disease in People Living with HIVU54MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI Jerris Robert Hedges · 2017 to 2026
$59.5M
Structure-Function Analytics CoreP01AI162242 · NIAID · DUKE UNIVERSITY · PI TOMARAS, GEORGIA DORIS · 2021 to 2025
$22.2M
Tracking and Evaluation CoreU54GM138062 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI KAHOLOKULA, JOSEPH KEAWE'AIMOKU · 2021 to 2025
$15.5M
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIVR01AI161010 · NIAID · DUKE UNIVERSITY · PI JOST, STEPHANIE, REEVES, ROGER KEITH · 2021 to 2025
$4.9M
Antigen-Specific NK Cell Memory Against SIV and HIV VaccinesR01AI120828 · NIAID · DUKE UNIVERSITY · PI REEVES, ROGER KEITH · 2017 to 2020
$3.5M
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid FolliclesR01AI143457 · NIAID · DUKE UNIVERSITY · PI REEVES, ROGER KEITH · 2019 to 2023
$3.1M
NIAID NIH HHS P01 AI162242NIAID NIH HHS R01 AI120828NIAID NIH HHS R01 AI143457NIAID NIH HHS R01 AI161010NIGMS NIH HHS U54 GM138062NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

People with HIV (PWH) on combination antiretroviral therapy (cART) are living longer lives due to modern cART advances and increased routine medical care. The full landscape of aging with HIV is unclear; given that HIV emerged relatively recently in human history and initially had a high mortality rate, there has not been a substantially aged population to evaluate. In this study, we set out to perform high-throughput plasma analyte profiling by multiplex analysis, focusing on various T helper (Th)-related cytokines, chemokines, and proinflammatory and anti-inflammatory cytokines. The primary goals being to provide reference ranges of these analytes for aging PWH cohorts, as well as testing the utility of high-throughput multiplex plasma assays. The cohort used in this study comprised age-matched healthy donors (32.6-73.5 years of age), PWH on cART (26.7-60.2 years of age), and viremic PWH (27.5-59.4 years of age). The patients in each group were then stratified across the age span to examine age-related impacts of these plasma biomarkers. Our results largely indicate feasibility of plasma analyte monitoring by multiplex and demonstrate a high degree of person-to-person variability regardless of age and HIV status. Nonetheless, we find multiple associations with age, duration of known infection, and viral load, all of which appear to be driven by either prolonged HIV disease progression or long-term use of cART.

Indexed as

CytokinesHIV InfectionsAdultAgedAgingBiomarkersChemokinesHumansMiddle AgedBiomarkersChemokinesCytokinesaginginflammationsoluble mediators

Identifiers

PMID37097212
PMCPMC11074629
OpenAlexW4366984727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.